Načítá se...
Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer’s Disease?
While the extensive hunt for therapeutics combating Alzheimer’s disease (AD) has fallen short of delivering effective treatments, breakthroughs towards understanding the disease mechanisms and identifying areas for future research have nevertheless been enabled. The majority of clinical trials with...
Uloženo v:
| Vydáno v: | Neurotherapeutics |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6277284/ https://ncbi.nlm.nih.gov/pubmed/30242774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-018-0668-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|